表紙:PHM(Population Health Management)の世界市場-2023年~2030年
市場調査レポート
商品コード
1316295

PHM(Population Health Management)の世界市場-2023年~2030年

Global Population Health Management Market - 2023-2030

出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
PHM(Population Health Management)の世界市場-2023年~2030年
出版日: 2023年07月27日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界のPHM(Population Health Management)市場は、2022年に213億米ドルに達し、2030年には543億米ドルに達するなど、有利な成長が予測されています。世界のPHM市場は、予測期間中(2023~2030年)に12.8%のCAGRを示すと予測されます。

すでに複数の医療提供者が、顧客のニーズに応じたさまざまなPHM政策を提供しています。健康維持組織プラン、優先プロバイダー組織プラン、ポイントオブサービスプラン、高免責医療プランなどがその例です。また、年2回の無料検診や、安い保険料でさらにカスタマイズが可能なPHM保険も販売されています。

市場力学

慢性疾患の増加が市場成長の原動力

慢性疾患はPHMを推進する大きな力です。長期的な病気を抱える患者は診療所で治療を受ける。例えば、糖尿病、高血圧、がんなどの慢性疾患の有病率の上昇は、市場の成長率に拍車をかけると思われます。慢性疾患、特に肥満と糖尿病は、高齢者の間で大きな悩みの種となっています。

例えば、世界中で糖尿病の有病率が上昇していることが市場拡大の原動力となっています。国際糖尿病連合によると、2021年までに約5,370億人が糖尿病に罹患し、これは世界の10人に1人を占める。慢性疾患の場合、患者記録の保存とモニタリングは極めて重要です。近年、慢性疾患に対するより効率的な治療法の開発が急増しています。治療需要の増加により、さらなる医療管理サービスが必要とされています。その結果、この側面が市場の成長を後押ししています。

医療企業による主要戦略が市場成長を促進する

医療機関を支援する革新的な製品を開発するため、複数のメーカーが研究開発に投資しています。

強固なPHMプログラム構築のためのインフラ投資が市場成長の妨げになる可能性が高い

PHMを実施するには、大量の健康データを収集、保存、処理、分析するための高度な情報技術(IT)システムとツールが必要です。これには、電子カルテ(EHR)システム、データ統合・アナリティクスプラットフォーム、PHMソフトウェア、安全なネットワーキングインフラなどが含まれます。これらのITシステムの調達、カスタマイズ、保守に関連するコストは相当なものになります。

COVID-19影響分析

COVID-19の流行により、あらゆる規模の医療機関が大きなプレッシャーにさらされており、世界中の医療施設が毎日訪れる多数の患者に圧倒されています。COVID-19の流行の増加により、いくつかの国では正確な診断および治療装置の需要が高まっています。

この点で、医療提供者がEHR、患者管理、ケア管理などのソリューションと、請求管理、支払い管理ソリューションなどの医療費支払者ソリューションとをシームレスに統合できるPHMソリューションが非常に有用であることが証明されています。さらに、この病気が世界的に急速に広がっているため、封鎖や規制が行われ、電子データ転送や請求管理の需要が高まっています。このため、予測期間中にPHMの導入が進むと予想されます。

ロシア・ウクライナ紛争の影響分析

ロシアとウクライナの紛争は、この地域の主要市場プレーヤーの数が少ないため、世界のPHM市場への影響は中程度と推定されます。しかし、原材料の輸出入の影響は、予測期間を通じて世界のPHM市場の成長にほとんど影響を与えないと予測されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 高騰する医療コストを抑制する必要性
      • 医療企業による主要戦略
    • 抑制要因
      • 強固なPHMプログラムを構築するためのインフラへの高額投資
    • 機会
      • PHMはプロアクティブで予防的なケアに焦点を当てる
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 ロシア・ウクライナ戦争影響分析

第8章 人工知能インパクト分析

第9章 コンポーネント別

  • ソフトウェア
  • サービス

第10章 提供モード別

  • オンプレミス
  • Webベース
  • クラウドベース

第11章 エンドユーザー別

  • 医療提供者
  • 医療保険者
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
      • その他アジア太平洋地域
  • 中東およびアフリカ
    • 主な地域別ダイナミクス

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • Allscripts Healthcare Solutions Inc
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Cerner Corporation
  • Conifer Health Solutions
  • Epic Systems Corporation
  • International Business Machines Corporation(IBM)
  • Health Catalyst
  • Koninklijke Philips NV
  • Mckesson Corporation
  • Optum Inc.
  • Verisk Analytics, Inc.

第15章 付録

目次
Product Code: HCIT239

Market Overview

The global population health management market reached US$ 21.3 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 54.3 billion by 2030. The global population health management market is expected to exhibit a CAGR of 12.8% during the forecast period (2023-2030).

Several healthcare providers are already offering a variety of population health management policies to customers based on their needs. Health maintenance organisation plans, preferred provider organisation plans, point of service plans, high deductible health plans, and others are examples of these. They also sell population health management policies that include free yearly and bi-annual check-ups as well as further customisation at cheap premium rates.

Market Dynamics

Rising Incidence of Chronic Disorders will drive the Market Growth

A chronic illness is a major force driving population health management. Patients with long-term ailments are treated at clinics. For instance, the rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, and others would fuel the market's growth rate. Chronic diseases, particularly obesity and diabetes, are a major source of concern among the elderly.

For instance, the rising prevalence of diabetes around the world is driving market expansion. According to the International Diabetes Federation, approximately 537 Billion individuals will have diabetes by 2021, accounting for one out of every ten people worldwide. In the case of chronic illness, keeping and monitoring patient records is critical. In recent years, there has been an upsurge in the development of more efficient treatment for chronic sickness. Because of the increase in treatment demand, additional healthcare management services are required. As a result, this aspect boosts market growth.

Key Strategies by the Healthcare Companies will Drive the Market Growth

Several manufacturers invest in research and development to develop innovative products to assist healthcare organizations. For instance, on July 27, 2022, Valenz announced the acquisition of Medical Cost Management Corporation, d.b.a. MCM Solutions for Better Health, and its subsidiary, Med-Care Management, Inc. (MCM), a leading provider of managed care and population health management programmes for self-funded plans across the whole continuum of care. Valenz announced the acquisition of VerifPoint, a credential verification organisation that is now known as VPoint, in May. Thus, this factor boosts market growth.

High Investments In Infrastructure to Set up a Robust PHM Program is Likely to Hamper the Market Growth

Implementing PHM requires sophisticated information technology (IT) systems and tools to collect, store, process, and analyze large volumes of health data. This includes electronic health record (EHR) systems, data integration and analytics platforms, population health management software, and secure networking infrastructure. The costs associated with procuring, customizing, and maintaining these IT systems can be substantial.

COVID-19 Impact Analysis

Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities worldwide have been overwhelmed by the large number of patients visiting them daily. The increasing prevalence of COVID-19 has driven the demand for accurate diagnosis and treatment devices in several countries.

In this regard, population health management solutions have proven to be very helpful, as they allow healthcare providers to seamlessly integrate solutions such as EHR, patient management, and care management to healthcare payer solutions such as claim management and payment management solutions. Moreover, the rapid spread of this disease worldwide has resulted in lockdowns and restrictions, increasing the demand for electronic data transfer and claim management. This is expected to increase the adoption of population health management in the forecast period.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global population health management market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global population health management market growth over the forecast period.

Segment Analysis

The global population health management market is segmented based on component, mode of delivery, end user and region.

Service Type Segment Aaccounts for 32.2% of Market Share dueing the forecast period

PHM services are increasingly being demanded by hospitals and other healthcare institutions in order to incorporate third parties in the evaluation of patient data. The need for PHM services is being driven in part by the need for integrated healthcare systems. Furthermore, rising government projects, as well as increased R&D spending by corporations to create unique items, have considerably assisted healthcare institutions.

For instance, on January 05, 2023, Gainwell Technologies has been awarded a $340 million contract for population health management (PHM) services by the California Department of Health Care Services (DHCS) as part of the California Advancing and Innovating Medi-Cal (CalAIM) initiative. DHCS officials have been giving stakeholders with frequent updates on deadlines and how the new service would operate. Thus, the following factors demonstrate segment expansion.

Geographical Analysis

North America Accounted for Approximately 39.4% of the Market Share Owing to the prevalence of diseases and Increasing Technological Advancements

The expanding federal medical mandates to reduce costs, increased government initiatives, increasing adoption of EHRs, and awareness of personalised and value-based reimbursements are the primary reasons driving population health management sector growth in the next years. The presence of significant industry players in the region, as well as company strategy, will drive the region growth.

For instance, on February 09, 2021, IBH (Integrated Behavioural Health, Inc.), a population and digital health services leader, has expanded its portfolio with the purchase of HMC HealthWorks ("HMC"), adding chronic condition management solutions, wellness, and pharmacy specialty services. The acquisition not only expands IBH's services to encompass condition management skills, but it also strengthens the company's experience in behavioural health while also servicing the special demands of Taft-Hartley, Government, Labour, and Trust Funds. As a result, factors promote segment growth.

Competitive Landscape

The major global players in the population health management market include: Allscripts Healthcare Solutions Inc., Cerner Corporation, Conifer Health Solutions, Epic Systems Corporation, International Business Machines Corporation (IBM), Health Catalyst, Koninklijke Philips NV, Mckesson Corporation, Optum Inc., Verisk Analytics, Inc and among others.

Why Purchase the Report?

  • To visualize the global population health management market segmentation based on component, mode of delivery, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of population health management market-level with all segments.
  • PDF report consists of a comprehensiveanalysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global population health management market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Mode of Delivery
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Need to curtail escalating healthcare costs
      • 4.1.1.2. Key strategies by the healthcare companies
    • 4.1.2. Restraints
      • 4.1.2.1. High investments in infrastructure to set up a robust PHM program
    • 4.1.3. Opportunity
      • 4.1.3.1. PHM focuses on proactive and preventive care
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Impact Analysis

8. Artificial Intelligence Impact Analysis

9. By Component

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.1.2. Market Attractiveness Index, By Component
  • 9.2. Software *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Services

10. By Mode of Delivery

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.1.2. Market Attractiveness Index, By Mode of Delivery
  • 10.2. On-Premise *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Web-based
  • 10.4. Cloud-Based

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Healthcare Providers *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Healthcare Payers
  • 11.4. Other

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.6.1. U.S.
      • 12.2.6.2. Canada
      • 12.2.6.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.6.1. Germany
      • 12.3.6.2. U.K.
      • 12.3.6.3. France
      • 12.3.6.4. Spain
      • 12.3.6.5. Italy
      • 12.3.6.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.6.1. Brazil
      • 12.4.6.2. Argentina
      • 12.4.6.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.6.1. China
      • 12.5.6.2. India
      • 12.5.6.3. Japan

Australia

      • 12.5.6.4. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Allscripts Healthcare Solutions Inc*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Cerner Corporation
  • 14.3. Conifer Health Solutions
  • 14.4. Epic Systems Corporation
  • 14.5. International Business Machines Corporation (IBM)
  • 14.6. Health Catalyst
  • 14.7. Koninklijke Philips NV
  • 14.8. Mckesson Corporation
  • 14.9. Optum Inc.
  • 14.10. Verisk Analytics, Inc.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us